News

A study found persistently high rates of overweight and obesity in the United States, highlighting significant racial and ethnic disparities.

Open-label data show sustained seizure reduction, stable safety, and improved quality of life in LGS treated with fenfluramine.

A study found that a nirsevimab immunization program reduced RSV-related hospitalizations by 85.9% in the first season and 55.3% in the second.

National data suggest universal high ED pediatric readiness may prevent 2,143 child deaths annually at modest per-child cost.

Whole-genome sequencing revealed extensive NICU transmission of MSSA and MRSA strains linked to invasive infection.

Get caught up with Contemporary Pediatrics! This list helps you navigate our top stories from the week, all in one place.

A study found no impact toward neurodevelopmental outcomes among toddlers exposed to mRNA COVID-19 vaccination in utero.

Host Brian Schroer, MD, interviews Sathya Areti, MD, about her case study presented at ACAAI 2025.

Host Brian Schroer, MD, interviews Melissa Ptak, DO, about her research presented at ACAAI 2025.

A new study finds high rates of neurodevelopmental diagnoses and service use among children undergoing heart surgery in infancy.

Phase trials show that Breztri Aerosphere triple therapy reduces annual severe exacerbation rates vs dual-combination inhaled therapy.

Quin Xie, PhD, and Jayne Danska, PhD, highlight increasing rates of type 2 diabetes in youth and suggest that measuring absolute gut bacterial abundance may improve risk prediction.

Part 4 highlights how expanding epinephrine delivery options can reduce barriers, support earlier administration, and improve real-world anaphylaxis outcomes.

In this segment, experts emphasize the importance of giving an infant experiencing anaphylaxis epinephrine at whatever dose may be available rather than delaying treatment.

In the second part of the special report, panelists delink epinephrine use from mandatory emergency department visits.

In the opening segment of this special report, panelists discuss updated anaphylaxis guidelines and early management priorities.

A study found that predischarge car seat tolerance screening was not associated with reduced 30-day mortality or hospital readmission among infants.

In the PROPEL 3 trial, oral infigratinib significantly increased annualized height velocity and improved body proportionality in children with achondroplasia.

A study found that children exposed to both home dampness and higher PM2.5 levels face a significantly greater risk of asthma.

Phase 2b maintenance data show sustained and new EASI, vIGA-AD, and itch responses with monthly or quarterly rezpegaldesleukin.

In LEVEL UP period 2, most patients who switched from dupilumab to upadacitinib achieved higher skin clearance and itch relief by 16 weeks.

The FDA declined approval of RGX-121 for MPS II, citing concerns about study design, control comparability, and surrogate end point validity.

Children who received early intervention services before aged 3 years showed academic benefits in third-grade math and English language arts.

Children exposed to both household dampness and higher PM2.5 levels in early life face a significantly increased risk of developing asthma.

A new review highlights how rising childhood obesity, genetic susceptibility, and early-life gut microbiota changes contribute to youth-onset type 2 diabetes.

A study found that while nearly one-third of US youth used generative artificial intelligence apps, usage patterns varied widely by age, timing, and intensity.

Sophie Driker, MPH, and Anne CC Lee, MD, MPH, discuss the effectiveness of WHO IMCI clinical signs for detecting sepsis and mortality risk in infants younger than 60 days.

In this Q&A, Matthew Neidell, PhD, reviews new data finding no link between community water fluoridation and adverse birth outcomes.